The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.
Physician Siddhartha Mukherjee explains how cellular science could lead to breakthroughs in the treatment of cancer, HIV, Type 1 diabetes and sickle cell anemia. His new book is The Song of the Cell.
In a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.
Colon cancer specialists worry that results of a study published this week in the New England Journal of Medicine could be misconstrued, and keep patients from getting lifesaving cancer screening.
Scientists have devised a new model for studying disorders like autism spectrum disorder and ADHD. It uses clusters of human brain cells grown inside the brain of a rat.
A New York woman seeking to end a dangerous ectopic pregnancy in a fallopian tube finds the procedure more complicated and expensive than expected — even in a state with liberal abortion laws.
For some people, a rare genetic mutation makes dementia inescapable. Three sisters have decided to confront fate with a genetic test and have joined a research project on possible treatments.
Though doctors and advocates have helped speed up access to the antiviral pills – of which the U.S. has enough to treat 1.7 million people – health providers are few and forms are still required.
As more states outlaw abortion, some define human life as starting at fertilization. Some patients and health care workers worry that this could jeopardize in vitro fertilization treatments.
Doctors say they're seeing a surge in the number of women who want their "tubes tied." But hospital capacity, paperwork, religion and personal opinion are just some of the reasons requests get denied.
These devices measure blood oxygen levels and can help identify when patients are dangerously ill. But research shows they can deliver misleading results for people with darker skin.
MRIs done early for uncomplicated low back pain and routine vitamin D tests "just to be thorough" are considered "low-value care" and can lead to further testing that can cost patients thousands.
